Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.

MLA

Wirsching, Hans-Georg, et al. “Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.” Cancers, vol. 13, no. 12, June 2021, p. 3073. EBSCOhost, https://doi.org/10.3390/cancers13123073.

APA

Wirsching, H.-G., Weller, M., Balabanov, S., & Roth, P. (2021). Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma. Cancers, 13(12), 3073. https://doi.org/10.3390/cancers13123073

Chicago

Wirsching, Hans-Georg, Michael Weller, Stefan Balabanov, and Patrick Roth. 2021. “Targeted Therapies and Immune Checkpoint Inhibitors in Primary CNS Lymphoma.” Cancers 13 (12): 3073. doi:10.3390/cancers13123073.